[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"non-tuberculous-mycobacterial-pneumonia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:non-tuberculous-mycobacterial-pneumonia":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,43,69,92,114],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100562415","cellular-markers-in-treated-or-untreated-non-tuberculous-mycobacterial-respiratory-infection-in-patients-with-cystic-fibrosis-100562415",false,"NCT06602869","Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis","Cellular Markers During a Non-tuberculous Mycobacterial Respiratory Infection, Treated or Untreated, in Patients With Cystic Fibrosis","MUCEM","Inclusion Criteria:\n\n* Patient ≥18 years\n* Patient previously included in the CIMeNT study\n* Patient with a confirmed diagnosis of cystic fibrosis regardless of CFTR genotype\n* Patient affiliated to the social security system\n* Patient registered in the French Cystic Fibrosis Registry\n* Adult patient capable of spontaneous expectoration or after induction\n\nExclusion Criteria:\n\n* Lung transplant patients\n* Person placed under judicial protection\n* Pregnant and breastfeeding women","ALL","18 Years",{"count":20,"type":21},76,"ESTIMATED","OBSERVATIONAL","This study evaluates a diagnostic serological test for Non-Tuberculous Mycobacteria (NTM) infection in cystic fibrosis patients by measuring T cell response. It aims to highlight a dynamic response associated to the pathogen's presence. This multicenter case-control study involves two populations, providing a better understanding of the circulating T-IFNγ-MNT response in these patients.",[25],"Non-Tuberculous Mycobacterial Pneumonia",[27,28,29],"Cystic Fibrosis","Interferon gamma release assay","Diagnostic Test","RECRUITING","2025-07-07",{"date":33,"type":34},"2025-07-10","ACTUAL",{"date":36,"type":34},"2024-09-17",{"date":38,"type":21},"2026-09-17",{"name":40,"class":41},"University Hospital, Montpellier","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":49,"targetDuration":51,"studyType":22,"phases":4,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":68},"100556226","mycobacteria-registry-study-prospective-observational-study-in-austria-100556226","NCT06522347","Mycobacteria Registry Study: Prospective Observational Study in Austria","Inclusion Criteria:\n\n* patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection\n* individuals aged 18 years or older\n* written informed consent\n\nExclusion Criteria:\n\n* to not comprehend and rightfully judge participation",{"count":50,"type":21},1000,"12 Months","The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is:\n\nWhat are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria?\n\nData from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.",[25,54],"Tuberculosis",[56,57,58],"Mycobacterium tuberculosis","Nontuberculous Mycobacteria","Mycobacterium Infections","2024-07-22",{"date":61,"type":34},"2024-07-26",{"date":63,"type":34},"2023-01-01",{"date":65,"type":21},"2053-12-31",{"name":67,"class":41},"Ludwig Boltzmann Institute for Lung Health",3,{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":76,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":78,"conditions":79,"keywords":81,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":42},"100547860","identification-of-new-biological-markers-for-the-progression-of-mycobacterium-abscessus-induced-lung-disease-in-cystic-fibrosis-100547860","NCT06413459","Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis","BioMol-MA","Inclusion Criteria:\n\n* Patients with a certain diagnosis of cystic fibrosis and visited during normal clinical practice, in accordance with the standard operating procedures in force at the Centres.\n* Both sexes\n* Age \\>18 years\n* Obtaining informed consent for patients (based on the procedures established by the protocol).\n\nExclusion Criteria:\n\n* Patients unable to understand the instructions and information provided and be able to adequately accept the study methods.",{"count":77,"type":21},40,"In this project the investigators aim to identify new biological markers by characterizing the response\u002Finflammation associated with the development and progression of M. abscessus lung disease in patients suffering from cystic fibrosis with the aim of increasing current knowledge available on the development and progression of lung disease.",[25,80],"Cystic Fibrosis Lung",[82],"scRNASec","2024-05-14",{"date":85,"type":34},"2024-05-16",{"date":87,"type":34},"2021-04-08",{"date":89,"type":21},"2027-03-30",{"name":91,"class":41},"Ospedale San Raffaele",{"id":93,"slug":94,"hasResults":11,"nctId":95,"briefTitle":96,"officialTitle":96,"acronym":4,"eligibilityCriteria":97,"healthyVolunteers":98,"sex":17,"minAge":18,"maxAge":99,"enrollmentInfo":100,"targetDuration":102,"studyType":22,"phases":4,"briefSummary":103,"conditions":104,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":109,"completionDateStruct":110,"leadSponsor":112,"locationsCount":42},"100527225","development-of-a-canadian-bronchiectasis-and-ntm-database-100527225","NCT06144996","Development of a Canadian Bronchiectasis and NTM Database","Inclusion Criteria:\n\n* Over the age of 18\n* Non-CF Bronchiectasis\n* Nontuberculosis Mycobacteria (NTM)\n\nExclusion Criteria:\n\n* Under the age of 18\n* CF bronchiectasis",true,"120 Years",{"count":101,"type":21},2000,"20 Years","The investigators aim to develop a comprehensive patient registry of patients with non-CF bronchiectasis and\u002For Nontuberculosis Mycobacteria (NTM)",[105,25],"Bronchiectasis","2023-11-17",{"date":108,"type":34},"2023-11-22",{"date":63,"type":34},{"date":111,"type":21},"2050-01",{"name":113,"class":41},"University of Calgary",{"id":115,"slug":116,"hasResults":11,"nctId":117,"briefTitle":118,"officialTitle":118,"acronym":119,"eligibilityCriteria":120,"healthyVolunteers":11,"sex":17,"minAge":102,"maxAge":4,"enrollmentInfo":121,"targetDuration":122,"studyType":22,"phases":4,"briefSummary":123,"conditions":124,"keywords":127,"overallStatus":131,"whyStopped":4,"lastUpdateSubmitDate":132,"lastUpdatePostDateStruct":133,"startDateStruct":135,"completionDateStruct":137,"leadSponsor":139,"locationsCount":4},"100357438","a-prospective-registry-for-patients-with-non-tuberculous-mycobacterial-ntm-pulmonary-disease-in-korea-100357438","NCT03934034","A Prospective Registry For Patients With Non-Tuberculous Mycobacterial (NTM) Pulmonary Disease in Korea.","NTM-KOREA","Inclusion Criteria:\n\n1. Clinical diagnosis of NTM pulmonary disease.\n2. The causative agent of NTM pulmonary disease includes: M. avium complex, or M. abscessus subspecies abscessus, or M. abscessus subspecies massiliense, or M. kansasii.\n3. Patients who starts new treatment (those who have previous history of treatment are eligible)\n\nExclusion Criteria\n\n1. Patients who have been treated for more than 4 weeks.\n2. The causative agent of NTM pulmonary disease is none of M. avium complex, M. abscessus subspecies abscessus, M. abscessus subspecies massiliense, or M. kansasii.",{"count":50,"type":21},"10 Years","The incidence and prevalence of pulmonary disease due to Non-tuberculous mycobacteria (NTM) is increasing worldwide, and this trend has been confirmed in Korea. Treatment of NTM pulmonary disease is difficult and usually requires more than two years of long-term treatment, and the antibiotic regimens used in treatment vary. Therefore, it is difficult to track the natural history of patients with NTM pulmonary disease, to evaluate the treatment outcome, and to understand the effect of specific medicines on the outcome. Establishing a prospective registry of patients with NTM pulmonary disease is expected to accurately evaluate the progress, treatment modality, and treatment outcome of NTM pulmonary disease.",[125,126,25],"Pulmonary Disease","Pulmonary Infection",[128,129,130],"NTM","Registry","Pulmonary infection","NOT_YET_RECRUITING","2019-04-30",{"date":134,"type":34},"2019-05-01",{"date":136,"type":21},"2019-04",{"date":138,"type":21},"2029-12",{"name":140,"class":41},"Seoul National University Hospital"]